Current Headlines

  1. GE Healthcare Licenses STEMCELL Technologies’ T-Cell Reagents

    In a further step to build its portfolio for the rapidly-growing cell therapy industry, GE Healthcare recently announced an agreement with STEMCELL Technologies Inc. of Vancouver, Canada to provide T-Cell reagents for commercial-scale cell therapy production.

  2. GE Healthcare And Sealed Air Enter Agreement On Single-Use Systems

    GE Healthcare’s Life Sciences business, a global provider of technologies and expertise to the biopharmaceutical and life sciences industries and Sealed Air Corporation, a global manufacturer of primary films for pharmaceutical solutions, recently announced the expansion of a strategic alliance designed to further the development and innovation in the biopharmaceuticals industry.

  3. Strategic Milestone For CSafe Global Cold Chain Biopharmaceutical Solutions Provider

    CSafe Global announces a significant strategic growth milestone with the manufacture of the 1000th RKN active container.

  4. MilliporeSigma To Provide Provantage® End-To-End Development And Manufacturing Services To Y-mAbs For Lead Antibody Compound

    MilliporeSigma will provide its Provantage® End-to-End development and manufacturing services to Y-mAbs Therapeutics, Inc. in support of Y-mAbs’ monoclonal antibody in late stage clinical development.

  5. Finesse Solutions Opens Branch Office In South Korea

    Finesse Solutions, Inc., a manufacturer of measurement and control solutions for life science process applications, has enhanced its business operations in Asia by opening a branch office in Seoul, South Korea. Finesse Korea joins other offices already established in Asia – in Singapore and Shanghai – to support the rapidly expanding Asia market.

  6. CSafe Celebrates New Company And Service Center In Puerto Rico

    The open house was at the company's new service centre adjacent to the island's Luis Muñoz Marín International Airport (SJU).

  7. Parker Domnick Hunter Boosts UK Single-Use Manufacturing Capabilities

    International bioprocessing solutions provider Parker domnick hunter has strengthened its ability to serve the European market by launching a single-use manifold manufacturing facility in the UK.

  8. Phillips-Medisize Completes Acquisition Of Injectronics

    Phillips-Medisize recently announced the completed acquisition of Injectronics Corporation, expanding their facilities to the Northeastern United States.

  9. MilliporeSigma Expands Excipients Portfolio, Adding Polymers For Sustained Release Injectables

    MilliporeSigma has entered into an agreement with PCAS S.A. (Longjumeau, France) to expand MilliporeSigma’s excipients portfolio. Under the agreement, MilliporeSigma will be the exclusive, global distributor of the Expansorb® line of biocompatible and biodegradable polymers.

  10. Recipharm Appoints New General Manager In Research Triangle Park

    Recipharm, the contract development and manufacturing organisation (CDMO), has appointed Ann Flodin as General Manager of its wholly owned new subsidiary Recipharm Laboratories Inc. in Research Triangle Park, North Carolina, USA, formerly Cirrus Pharmaceuticals Inc.